17 results on '"Abegg, Vanessa Fabienne"'
Search Results
2. Open microfluidics: droplet microarrays as next generation multiwell plates for high throughput screening
- Author
-
Strutt, Robert, primary, Xiong, Bijing, additional, Abegg, Vanessa Fabienne, additional, and Dittrich, Petra S., additional
- Published
- 2024
- Full Text
- View/download PDF
3. Mechanisms of hepatocellular toxicity associated with the components of St. John's Wort extract hypericin and hyperforin in HepG2 and HepaRG cells.
- Author
-
Abegg, Vanessa Fabienne, Panajatovic, Miljenko Valentin, Mancuso, Riccardo Vincenzo, Allard, Julien Arthur, Duthaler, Urs, Odermatt, Alex, Krähenbühl, Stephan, and Bouitbir, Jamal
- Subjects
- *
HYPERICIN , *SEROTONIN uptake inhibitors , *SUPEROXIDES , *MITOCHONDRIAL DNA , *HEPATOTOXICOLOGY , *CHARGE exchange - Abstract
St. John's Wort preparations are used for the treatment of mild to moderate depression. They are usually well tolerated but can cause adverse reactions including liver toxicity in rare cases. To date, the mechanism(s) underlying the hepatotoxicity of St. John's Wort extracts are poorly investigated. We studied the hepatocellular toxicity of hypericin and hyperforin as the two main ingredients of St. John's Wort extracts in HepG2 and HepaRG cells and compared the effects to citalopram (a synthetic serotonin uptake inhibitor) with a special focus on mitochondrial toxicity and oxidative stress. In HepG2 cells, hypericin was membrane-toxic at 100 µM and depleted ATP at 20 µM. In HepaRG cells, ATP depletion started at 5 µM. In comparison, hyperforin and citalopram were not toxic up to 100 µM. In HepG2 cells, hypericin decreased maximal respiration starting at 2 µM and mitochondrial ATP formation starting at 10 µM but did not affect glycolytic ATP production. Hypericin inhibited the activity of complex I, II and IV of the electron transfer system and caused mitochondrial superoxide accumulation in cells. The protein expression of mitochondrial superoxide dismutase 2 (SOD2) and thioredoxin 2 (TRX2) and total and reduced glutathione decreased in cells exposed to hypericin. Finally, hypericin diminished the mitochondrial DNA copy number and caused cell necrosis but not apoptosis. In conclusion, hypericin, but not hyperforin or citalopram, is a mitochondrial toxicant at low micromolar concentrations. This mechanism may contribute to the hepatotoxicity occasionally observed in susceptible patients treated with St. John's Wort preparations. [Display omitted] • Exposure to hypericin induces cytotoxicity in hepatic HepG2 and HepaRG cells. • Hypericin decreases mitochondrial ATP production in HepG2 cells. • Hypericin inhibited the activity of complex I, II and IV of the ETS in HepG2 cells. • Hypericin induces mitochondrial oxidative stress in HepG2 cells. • Hypericin diminishes the mitochondrial DNA copy number and causes cell necrosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Transplacental passage of hyperforin, hypericin, and valerenic acid
- Author
-
Spiess, Deborah; https://orcid.org/0000-0001-8887-6194, Abegg, Vanessa Fabienne, Chauveau, Antoine, Rath, Joshua, Treyer, Andrea, Reinehr, Michael; https://orcid.org/0000-0003-3321-0920, Kuoni, Sabrina, Oufir, Mouhssin, Potterat, Olivier; https://orcid.org/0000-0001-5962-6516, Hamburger, Matthias; https://orcid.org/0000-0001-9331-273X, Simões-Wüst, Ana Paula; https://orcid.org/0000-0002-4489-0952, Spiess, Deborah; https://orcid.org/0000-0001-8887-6194, Abegg, Vanessa Fabienne, Chauveau, Antoine, Rath, Joshua, Treyer, Andrea, Reinehr, Michael; https://orcid.org/0000-0003-3321-0920, Kuoni, Sabrina, Oufir, Mouhssin, Potterat, Olivier; https://orcid.org/0000-0001-5962-6516, Hamburger, Matthias; https://orcid.org/0000-0001-9331-273X, and Simões-Wüst, Ana Paula; https://orcid.org/0000-0002-4489-0952
- Abstract
Safe medications for mild mental diseases in pregnancy are needed. Phytomedicines from St. John’s wort and valerian are valid candidates, but safety data in pregnancy are lacking. The transplacental transport of hyperforin and hypericin (from St. John’s wort), and valerenic acid (from valerian) was evaluated using the ex vivo cotyledon perfusion model (4 h perfusions, term placentae) and, in part, the in vitro Transwell assay with BeWo b30 cells. Antipyrine was used for comparison in both models. U(H)PLC-MS/MS bioanalytical methods were developed to quantify the compounds. Perfusion data obtained with term placentae showed that only minor amounts of hyperforin passed into the fetal circuit, while hypericin did not cross the placental barrier and valerenic acid equilibrated between the maternal and fetal compartments. None of the investigated compounds affected metabolic, functional, and histopathological parameters of the placenta during the perfusion experiments. Data from the Transwell model suggested that valerenic acid does not cross the placental cell layer. Taken together, our data suggest that throughout the pregnancy the potential fetal exposure to hypericin and hyperforin – but not to valerenic acid – is likely to be minimal.
- Published
- 2023
5. Transplacental passage of hyperforin, hypericin, and valerenic acid
- Author
-
Spiess, Deborah, primary, Abegg, Vanessa Fabienne, additional, Chauveau, Antoine, additional, Rath, Joshua, additional, Treyer, Andrea, additional, Reinehr, Michael, additional, Kuoni, Sabrina, additional, Oufir, Mouhssin, additional, Potterat, Olivier, additional, Hamburger, Matthias, additional, and Simões-Wüst, Ana Paula, additional
- Published
- 2023
- Full Text
- View/download PDF
6. Placental Passage of Protopine in an Ex Vivo Human Perfusion System
- Author
-
Spiess, Deborah, Abegg, Vanessa Fabienne, Chauveau, Antoine, Treyer, Andrea, Reinehr, Michael, Oufir, Mouhssin, Duong, Elisa, Potterat, Olivier, Hamburger, Matthias, Simões-Wüst, Ana Paula, University of Zurich, and Simões-Wüst, Ana Paula
- Subjects
Pharmacology ,1602 Analytical Chemistry ,3002 Drug Discovery ,Organic Chemistry ,3003 Pharmaceutical Science ,2707 Complementary and Alternative Medicine ,Pharmaceutical Science ,610 Medicine & health ,Analytical Chemistry ,3004 Pharmacology ,Complementary and alternative medicine ,10049 Institute of Pathology and Molecular Pathology ,1313 Molecular Medicine ,Drug Discovery ,Molecular Medicine ,10026 Clinic for Obstetrics ,1605 Organic Chemistry - Abstract
The placental passage of protopine was investigated with a human ex vivo placental perfusion model. The model was first validated with diazepam and citalopram, 2 compounds known to cross the placental barrier, and antipyrine as a positive control. All compounds were quantified by partially validated U(H)PLC-MS/MS bioanalytical methods. Protopine was transferred from the maternal to the fetal circuit, with a steady-state reached after 90 min. The study compound did not affect placental viability or functionality, as glucose consumption, lactate production, and beta-human chorionic gonadotropin, and leptin release remained constant. Histopathological evaluation of all placental specimens showed unremarkable, age-appropriate parenchymal maturation with no pathologic findings.
- Published
- 2022
7. Placental Passage of Protopine in an Ex Vivo Human Perfusion System
- Author
-
Spiess, Deborah; https://orcid.org/0000-0001-8887-6194, Abegg, Vanessa Fabienne, Chauveau, Antoine, Treyer, Andrea, Reinehr, Michael; https://orcid.org/0000-0003-3321-0920, Oufir, Mouhssin, Duong, Elisa, Potterat, Olivier; https://orcid.org/0000-0001-5962-6516, Hamburger, Matthias; https://orcid.org/0000-0001-9331-273X, Simões-Wüst, Ana Paula; https://orcid.org/0000-0002-4489-0952, Spiess, Deborah; https://orcid.org/0000-0001-8887-6194, Abegg, Vanessa Fabienne, Chauveau, Antoine, Treyer, Andrea, Reinehr, Michael; https://orcid.org/0000-0003-3321-0920, Oufir, Mouhssin, Duong, Elisa, Potterat, Olivier; https://orcid.org/0000-0001-5962-6516, Hamburger, Matthias; https://orcid.org/0000-0001-9331-273X, and Simões-Wüst, Ana Paula; https://orcid.org/0000-0002-4489-0952
- Abstract
The placental passage of protopine was investigated with a human ex vivo placental perfusion model. The model was first validated with diazepam and citalopram, 2 compounds known to cross the placental barrier, and antipyrine as a positive control. All compounds were quantified by partially validated U(H)PLC-MS/MS bioanalytical methods. Protopine was transferred from the maternal to the fetal circuit, with a steady-state reached after 90 min. The study compound did not affect placental viability or functionality, as glucose consumption, lactate production, and beta-human chorionic gonadotropin, and leptin release remained constant. Histopathological evaluation of all placental specimens showed unremarkable, age-appropriate parenchymal maturation with no pathologic findings.
- Published
- 2022
8. Medicinal Plants for the Treatment of Mental Diseases in Pregnancy: An In Vitro Safety Assessment
- Author
-
Spiess, Deborah; https://orcid.org/0000-0001-8887-6194, Winker, Moritz, Chauveau, Antoine, Abegg, Vanessa Fabienne, Potterat, Olivier; https://orcid.org/0000-0001-5962-6516, Hamburger, Matthias; https://orcid.org/0000-0001-9331-273X, Gründemann, Carsten, Simões-Wüst, Ana Paula; https://orcid.org/0000-0002-4489-0952, Spiess, Deborah; https://orcid.org/0000-0001-8887-6194, Winker, Moritz, Chauveau, Antoine, Abegg, Vanessa Fabienne, Potterat, Olivier; https://orcid.org/0000-0001-5962-6516, Hamburger, Matthias; https://orcid.org/0000-0001-9331-273X, Gründemann, Carsten, and Simões-Wüst, Ana Paula; https://orcid.org/0000-0002-4489-0952
- Abstract
Pregnancy is a critical period for medical care, during which the well-being of woman and fetus must be considered. This is particularly relevant in managing non-psychotic mental disorders since treatment with central nervous system-active drugs and untreated NMDs may have negative effects. Some well-known herbal preparations (phytopharmaceuticals), including St. Johnʼs wort, California poppy, valerian, lavender, and hops, possess antidepressant, sedative, anxiolytic, or antidepressant properties and could be used to treat mental diseases such as depression, restlessness, and anxiety in pregnancy. Our goal was to assess their safety in vitro, focusing on cytotoxicity, induction of apoptosis, genotoxicity, and effects on metabolic properties and differentiation in cells widely used as a placental cell model (BeWo b30 placenta choriocarcinoma cells). The lavender essential oil was inconspicuous in all experiments and showed no detrimental effects. At low-to-high concentrations, no extract markedly affected the chosen safety parameters. At an artificially high concentration of 100 µg/mL, extracts from St. Johnʼs wort, California poppy, valerian, and hops had minimal cytotoxic effects. None of the extracts resulted in genotoxic effects or altered glucose consumption or lactate production, nor did they induce or inhibit BeWo b30 cell differentiation. This study suggests that all tested preparations from St. Johnʼs wort, California poppy, valerian, lavender, and hops, in concentrations up to 30 µg/mL, do not possess any cytotoxic or genotoxic potential and do not compromise placental cell viability, metabolic activity, and differentiation. Empirical and clinical studies during pregnancy are needed to support these in vitro data.
- Published
- 2022
9. Medicinal Plants for the Treatment of Mental Diseases in Pregnancy: An In Vitro Safety Assessment
- Author
-
Spiess, Deborah, Winker, Moritz, Chauveau, Antoine, Abegg, Vanessa Fabienne, Potterat, Olivier, Hamburger, Matthias, Gründemann, Carsten, Simões-Wüst, Ana Paula, University of Zurich, and Simões-Wüst, Ana Paula
- Subjects
Pharmacology ,1602 Analytical Chemistry ,3002 Drug Discovery ,Organic Chemistry ,3003 Pharmaceutical Science ,2707 Complementary and Alternative Medicine ,Pharmaceutical Science ,610 Medicine & health ,Analytical Chemistry ,3004 Pharmacology ,Complementary and alternative medicine ,1313 Molecular Medicine ,Drug Discovery ,Molecular Medicine ,10026 Clinic for Obstetrics ,1605 Organic Chemistry - Published
- 2022
- Full Text
- View/download PDF
10. Retraction: Placental Passage of Humulone and Protopine in an Ex Vivo Human Perfusion System
- Author
-
Spiess, Deborah, Abegg, Vanessa Fabienne, Chauveau, Antoine, Treyer, Andrea, Reinehr, Michael, Oufir, Mouhssin, Duong, Elisa, Potterat, Olivier, Hamburger, Matthias, Simões-Wüst, Ana Paula, University of Zurich, and Hamburger, Matthias
- Subjects
1602 Analytical Chemistry ,3004 Pharmacology ,10049 Institute of Pathology and Molecular Pathology ,1313 Molecular Medicine ,3002 Drug Discovery ,3003 Pharmaceutical Science ,2707 Complementary and Alternative Medicine ,610 Medicine & health ,1605 Organic Chemistry - Published
- 2021
11. Correction: Placental Passage of Humulone and Protopine in an Ex Vivo Human Perfusion System
- Author
-
Spiess, Deborah, primary, Abegg, Vanessa Fabienne, primary, Chauveau, Antoine, additional, Treyer, Andrea, additional, Reinehr, Michael, additional, Oufir, Mouhssin, additional, Duong, Elisa, additional, Potterat, Olivier, additional, Hamburger, Matthias, additional, and Simões-Wüst, Ana Paula, additional
- Published
- 2021
- Full Text
- View/download PDF
12. Medicinal Plants for the Treatment of Mental Diseases in Pregnancy: An In Vitro Safety Assessment
- Author
-
Spiess, Deborah, additional, Winker, Moritz, additional, Chauveau, Antoine, additional, Abegg, Vanessa Fabienne, additional, Potterat, Olivier, additional, Hamburger, Matthias, additional, Gründemann, Carsten, additional, and Simões-Wüst, Ana Paula, additional
- Published
- 2021
- Full Text
- View/download PDF
13. Placental Passage of Humulone and Protopine in an Ex Vivo Human Perfusion System
- Author
-
Spiess, Deborah, primary, Abegg, Vanessa Fabienne, primary, Chauveau, Antoine, additional, Treyer, Andrea, additional, Reinehr, Michael, additional, Oufir, Mouhssin, additional, Duong, Elisa, additional, Potterat, Olivier, additional, Hamburger, Matthias, additional, and Simões-Wüst, Ana Paula, additional
- Published
- 2021
- Full Text
- View/download PDF
14. Placental Passage of Protopine in an Ex Vivo Human Perfusion System.
- Author
-
Spiess, Deborah, Abegg, Vanessa Fabienne, Chauveau, Antoine, Treyer, Andrea, Reinehr, Michael, Oufir, Mouhssin, Duong, Elisa, Potterat, Olivier, Hamburger, Matthias, and Simões-Wüst, Ana Paula
- Subjects
- *
MATERNAL-fetal exchange , *ALKALOIDS , *PLACENTA , *PLANT extracts , *MOLECULAR structure , *PERFUSION - Abstract
The placental passage of protopine was investigated with a human ex vivo placental perfusion model. The model was first validated with diazepam and citalopram, 2 compounds known to cross the placental barrier, and antipyrine as a positive control. All compounds were quantified by partially validated U(H)PLC-MS/MS bioanalytical methods. Protopine was transferred from the maternal to the fetal circuit, with a steady-state reached after 90 min. The study compound did not affect placental viability or functionality, as glucose consumption, lactate production, and beta-human chorionic gonadotropin, and leptin release remained constant. Histopathological evaluation of all placental specimens showed unremarkable, age-appropriate parenchymal maturation with no pathologic findings. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
15. Placental Passage of Humulone and Protopine in an Ex Vivo Human Perfusion System#.
- Author
-
Spiess, Deborah, Abegg, Vanessa Fabienne, Chauveau, Antoine, Treyer, Andrea, Reinehr, Michael, Oufir, Mouhssin, Duong, Elisa, Potterat, Olivier, Hamburger, Matthias, and Simões-Wüst, Ana Paula
- Subjects
- *
BIOLOGICAL models , *CITALOPRAM , *MATERNAL-fetal exchange , *ALKALOIDS , *CELL survival , *GONADOTROPIN , *PLACENTA , *MASS spectrometry , *DESCRIPTIVE statistics , *PLANT extracts , *MOLECULAR structure , *PERFUSION , *DIAZEPAM - Abstract
The placental passage of humulone and protopine was investigated with a human ex vivo placental perfusion model. The model was first validated with diazepam and citalopram, 2 compounds known to cross the placental barrier, and antipyrine as a positive control. All compounds were quantified by partially validated U(H)PLC-MS/MS bioanalytical methods. Only a small portion of humulone initially present in the maternal circuit reached the fetal circuit. The humulone concentration in the maternal circuit rapidly decreased, likely due to metabolization in the placenta. Protopine was transferred from the maternal to the fetal circuit, with a steady-state reached after 90 min. None of the study compounds affected placental viability or functionality, as glucose consumption, lactate production, beta-human chorionic gonadotropin, and leptin release remained constant. Histopathological evaluation of all placental specimens showed unremarkable, age-appropriate parenchymal maturation with no pathologic findings. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
16. Placental Passage of Humulone and Protopine in an Ex Vivo Human Perfusion System#.
- Author
-
Spiess, Deborah, Abegg, Vanessa Fabienne, Chauveau, Antoine, Treyer, Andrea, Reinehr, Michael, Oufir, Mouhssin, Duong, Elisa, Potterat, Olivier, Hamburger, Matthias, and Simões-Wüst, Ana Paula
- Subjects
BIOLOGICAL models ,CITALOPRAM ,MATERNAL-fetal exchange ,ALKALOIDS ,CELL survival ,GONADOTROPIN ,PLACENTA ,MASS spectrometry ,DESCRIPTIVE statistics ,PLANT extracts ,MOLECULAR structure ,PERFUSION ,DIAZEPAM - Abstract
The placental passage of humulone and protopine was investigated with a human ex vivo placental perfusion model. The model was first validated with diazepam and citalopram, 2 compounds known to cross the placental barrier, and antipyrine as a positive control. All compounds were quantified by partially validated U(H)PLC-MS/MS bioanalytical methods. Only a small portion of humulone initially present in the maternal circuit reached the fetal circuit. The humulone concentration in the maternal circuit rapidly decreased, likely due to metabolization in the placenta. Protopine was transferred from the maternal to the fetal circuit, with a steady-state reached after 90 min. None of the study compounds affected placental viability or functionality, as glucose consumption, lactate production, beta-human chorionic gonadotropin, and leptin release remained constant. Histopathological evaluation of all placental specimens showed unremarkable, age-appropriate parenchymal maturation with no pathologic findings. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
17. Medicinal Plants for the Treatment of Mental Diseases in Pregnancy: An In Vitro Safety Assessment.
- Author
-
Spiess D, Winker M, Chauveau A, Abegg VF, Potterat O, Hamburger M, Gründemann C, and Simões-Wüst AP
- Subjects
- Antidepressive Agents pharmacology, Antidepressive Agents therapeutic use, Female, Glucose, Humans, Hypnotics and Sedatives therapeutic use, Lactates, Phytotherapy, Placenta, Plant Extracts pharmacology, Plant Extracts therapeutic use, Pregnancy, Anti-Anxiety Agents, Hypericum, Mental Disorders drug therapy, Oils, Volatile pharmacology, Oils, Volatile therapeutic use, Plants, Medicinal, Valerian
- Abstract
Pregnancy is a critical period for medical care, during which the well-being of woman and fetus must be considered. This is particularly relevant in managing non-psychotic mental disorders since treatment with central nervous system-active drugs and untreated NMDs may have negative effects. Some well-known herbal preparations (phytopharmaceuticals), including St. John's wort, California poppy, valerian, lavender, and hops, possess antidepressant, sedative, anxiolytic, or antidepressant properties and could be used to treat mental diseases such as depression, restlessness, and anxiety in pregnancy. Our goal was to assess their safety in vitro , focusing on cytotoxicity, induction of apoptosis, genotoxicity, and effects on metabolic properties and differentiation in cells widely used as a placental cell model (BeWo b30 placenta choriocarcinoma cells). The lavender essential oil was inconspicuous in all experiments and showed no detrimental effects. At low-to-high concentrations, no extract markedly affected the chosen safety parameters. At an artificially high concentration of 100 µg/mL, extracts from St. John's wort, California poppy, valerian, and hops had minimal cytotoxic effects. None of the extracts resulted in genotoxic effects or altered glucose consumption or lactate production, nor did they induce or inhibit BeWo b30 cell differentiation. This study suggests that all tested preparations from St. John's wort, California poppy, valerian, lavender, and hops, in concentrations up to 30 µg/mL, do not possess any cytotoxic or genotoxic potential and do not compromise placental cell viability, metabolic activity, and differentiation. Empirical and clinical studies during pregnancy are needed to support these in vitro data., Competing Interests: The authors declare that they have no conflict of interest., (The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.